Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Nuokangda is a leading Chinese Contract Research Organization (CRO) specializing in pharmaceutical R&D services. The company provides integrated solutions covering drug formulation development, clinical trial management, and regulatory submission for both generic and innovative drugs. With a strong focus on complex formulations and the consistency evaluation of generic drugs, Nuokangda supports pharmaceutical companies in accelerating their product pipelines. Their expertise spans multiple therapeutic areas, including cardiovascular, metabolic, and oncology treatments. The company operates advanced technology platforms for drug delivery systems, ensuring high-quality and efficient drug development processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 北京诺康达.